Hyperthermic Intrathoracic Chemotherapy (HITOC) Improves Malignant Pleural Mesothelioma Control Through a Tumor Specific Cytotoxic Immune Response

Cavin, S.Hao, Y.Gkasti, AspasiaChriqui, L. E.Marie, D.Abdelnour, E.Gonzalez, M.Krueger, T.Dyson, P. J.Peters, S.Meylan, E.Perentes, J. Y.2024-04-032024-04-032024-04-032023-06-0910.1093/bjs/znad178.002https://infoscience.epfl.ch/handle/20.500.14299/206913WOS:001183197500004Life Sciences & BiomedicineHyperthermic Intrathoracic Chemotherapy (HITOC) Improves Malignant Pleural Mesothelioma Control Through a Tumor Specific Cytotoxic Immune Responsetext::conference output::conference proceedings::conference paper